Retrograde Type A Aortic Dissection After Endovascular Stent Graft Placement for Treatment of Type B Dissection

Zhi Hui Dong, Wei Fu, Yu Qi Wang, +9

Circulation

Incidence and risk factors for retrograde type A dissection and stent graft-induced new entry after thoracic endovascular aortic repair

Tao Ma, Zhi Hui Dong, Wei Fu, +10

Journal of Vascular Surgery

Endovascular TechniqueVascular SurgeryThoracic SurgerySurgeryEndovascular Management +5

miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2

Tong Li, Jue Yang, Xiaobo Lv, +4

Biotechnology Letters

Colorectal Carcinoma CellsOncologyMedicineColorectal CancerPathology +7

A preoperative mortality risk assessment model for Stanford type A acute aortic dissection

Juntao Kuang, Jue Yang, Qiuji Wang, +3

BMC Cardiovascular Disorders

Purified CD34+ cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial

Zhihui Dong, Tianyue Pan, Yuan Fang, +18

EBioMedicine

Predictors and Treatments of Proglide-Related Complications in Percutaneous Endovascular Aortic Repair

Guohua Hu, Bin Chen, Weiguo Fu, +5

PLoS ONE

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

Tianyue Pan, Hao Liu, Yuan Fang, +16

Stem Cell Research & Therapy

Early outcomes of the conformable stent graft for acute complicated and uncomplicated type B aortic dissection

Ting Zhu, Yi Si, Yuan Fang, +5

Journal of Vascular Surgery

Endovascular TechniqueVascular SurgeryEarly OutcomesConformable Stent GraftSurgery +4

Predicting Intensive Care Unit Length of Stay After Acute Type A Aortic Dissection Surgery Using Machine Learning

Qiuying Chen, Bin Zhang, Jue Yang, +9

Frontiers in Cardiovascular Medicine

A Five-Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis-Induced No-Option Critical Limb Ischemia

Yuan Fang, Zheng Wei, Bin Chen, +13

Stem Cells Translational Medicine